Koen J. Hartemink

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

Krijn K. Dijkstra, Chiara M. Cattaneo, Fleur Weeber et al. · Cell · 2018 · 1K citations · Full text

Tumor-reactive T Cells, Cell Therapy, Cancer Immunosurveillance +10

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

Stefano Trebeschi, Silvia Girolama Drago, Nicolai J. Birkbak et al. · Annals of Oncology · 2019 · 533 citations · Full text

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer

Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen et al. · Nature Medicine · 2021 · 336 citations

Pd-1 Blockade, Medicine, Tumor Immunity +9

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Josine M.M.F. Quispel-Janssen, Vincent van der Noort, Jeltje F. de Vries et al. · Journal of Thoracic Oncology · 2018 · 244 citations · Full text

Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine

Krijn K. Dijkstra, Kim Monkhorst, Luuk J. Schipper et al. · Cell Reports · 2020 · 244 citations · Full text